DuPont Partners with Evogene on Corn Seed TreatmentsDuPont Partners with Evogene on Corn Seed Treatments
July 27, 2017

U.S. hybrid seed producer DuPont Pioneer and Israeli crop productivity biotechnology firm Evogene Ltd. have joined forces in a multi-year collaboration to research and develop microbiome-based seed treatments for corn that will enable farmers to bring in higher yields and leverage the two companies’ technologies.
“This is an important step forward in our efforts to discover, develop, and provide advanced seed-applied technologies,” Neal Gutterson, vice president of research and development at DuPont Pioneer, said in a statement. “Our relationship with Evogene is consistent with our history of collaboration to advance science-based customer solutions and our open innovation strategy.”
DuPont will give Evogene access to its seed treatment application technology and product development resources, and Evogene will contribute its predictive computational biology platform used to uncover plant/microbiome interactions, as well as the Israeli firm’s fermentation and microbial formulation technologies.
“We believe microbiome-based biologicals will be an important and valuable tool for farmers in driving agricultural productivity. Evogene’s biological predictive technology platform drives research and development of such novel ag-biological solutions and generates significant positive outcomes,” said Ofer Haviv, president and chief executive officer of Evogene in a DuPont press release.
The financial terms of the agreement were not disclosed.
For more articles, news, and equipment reviews, visit our Equipment Zones
You May Also Like